122 related articles for article (PubMed ID: 1725818)
1. [Function and diseases of peroxisomes].
Wehr H; Zaremba J
Neurol Neurochir Pol; 1991; 25(6):769-74. PubMed ID: 1725818
[TBL] [Abstract][Full Text] [Related]
2. [Peroxisomes and peroxisomal diseases].
Petelenz M; Gonciarz Z; Grzybek H; Panz B
Postepy Hig Med Dosw; 1991; 45(1-2):77-99. PubMed ID: 1717967
[TBL] [Abstract][Full Text] [Related]
3. [Peroxisomes and neurologic diseases].
Sereni C; Paturneau-Jouas M
Rev Neurol (Paris); 1989; 145(5):341-9. PubMed ID: 2472665
[TBL] [Abstract][Full Text] [Related]
4. [Peroxisomal neurologic diseases and Refsum disease: very long chain fatty acids and phytanic acid as diagnostic markers].
Molzer B; Stöckler S; Bernheimer H
Wien Klin Wochenschr; 1992; 104(21):665-70. PubMed ID: 1282286
[TBL] [Abstract][Full Text] [Related]
5. Complementation analysis of peroxisomal disorders and classical Refsum.
Poll-The BT; Skjeldal OH; Stokke O; Demaugre F; Saudubray JM
Prog Clin Biol Res; 1990; 321():537-43. PubMed ID: 1691507
[No Abstract] [Full Text] [Related]
6. [Zellweger syndrome and other peroxisomal disorders: I. Clinical characteristics of a recently discovered group of diseases].
Heymans HS; Wanders RJ; Schutgens RB; van den Bosch H; Tager JM; Barth PG
Ned Tijdschr Geneeskd; 1990 Mar; 134(13):634-9. PubMed ID: 1690863
[No Abstract] [Full Text] [Related]
7. Very long-chain fatty acids in peroxisomal disease.
Poulos A; Beckman K; Johnson DW; Paton BC; Robinson BS; Sharp P; Usher S; Singh H
Adv Exp Med Biol; 1992; 318():331-40. PubMed ID: 1378993
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis of peroxisomal disorders with neurological involvement.
Molzer B
Padiatr Padol; 1993; 28(1):43-8. PubMed ID: 8446428
[TBL] [Abstract][Full Text] [Related]
9. Pseudo infantile Refsum's disease: catalase-deficient peroxisomal particles with partial deficiency of plasmalogen synthesis and oxidation of fatty acids.
Aubourg P; Kremser K; Roland MO; Rocchiccioli F; Singh I
Pediatr Res; 1993 Sep; 34(3):270-6. PubMed ID: 7510868
[TBL] [Abstract][Full Text] [Related]
10. In situ genetic complementation analysis of cells with generalized peroxisomal dysfunction.
Singh AK; Kulvatunyou N; Singh I; Stanley WS
Hum Hered; 1989; 39(5):298-301. PubMed ID: 2482247
[TBL] [Abstract][Full Text] [Related]
11. Phytanic acid and very long chain fatty acids in genetic peroxisomal disorders.
Molzer B; Kainz-Korschinsky M; Sundt-Heller R; Bernheimer H
J Clin Chem Clin Biochem; 1989 May; 27(5):309-14. PubMed ID: 2474624
[TBL] [Abstract][Full Text] [Related]
12. [Zellweger syndrome, neonatal adrenoleukodystrophy or infantile Refsum's disease in a case with generalized peroxisome defect?].
Schmitt K; Molzer B; Stöckler S; Tulzer G; Tulzer W
Wien Klin Wochenschr; 1993; 105(11):320-2. PubMed ID: 7687405
[TBL] [Abstract][Full Text] [Related]
13. [Liver pathologies due to peroxisome disorders].
Lovisetto P; Raviolo P
Recenti Prog Med; 1994 Feb; 85(2):134-41. PubMed ID: 8184191
[TBL] [Abstract][Full Text] [Related]
14. Plasma polyenoic very-long-chain fatty acids in peroxisomal disease: biochemical discrimination of Zellweger's syndrome from other phenotypes.
Poulos A; Sharp P; Johnson D
Neurology; 1989 Jan; 39(1):44-7. PubMed ID: 2462697
[TBL] [Abstract][Full Text] [Related]
15. [Clinical and molecular aspects of peroxisome-deficient disorders].
Suzuki Y; Shimozawa N; Orii T
Nihon Rinsho; 1993 Sep; 51(9):2353-8. PubMed ID: 7692118
[TBL] [Abstract][Full Text] [Related]
16. Postnatal diagnosis of peroxisomal disorders: a biochemical approach.
Wanders RJ; Schutgens RB; Barth PG; Tager JM; van den Bosch H
Biochimie; 1993; 75(3-4):269-79. PubMed ID: 7685190
[TBL] [Abstract][Full Text] [Related]
17. The deficient degradation of synthetic 2- and 3-methyl-branched fatty acids in fibroblasts from patients with peroxisomal disorders.
Van Veldhoven PP; Huang S; Eyssen HJ; Mannaerts GP
J Inherit Metab Dis; 1993; 16(2):381-91. PubMed ID: 7692128
[TBL] [Abstract][Full Text] [Related]
18. Analysis of very long-chain fatty acids and plasmalogen in the erythrocyte membrane: a simple method for the detection of peroxisomal disorders and discrimination between adrenoleukodystrophy and Zellweger syndrome.
Tanaka K; Nishizawa K; Yamamoto H; Naruto T; Izeki E; Taga T; Shimada M; Saeki Y
Neuropediatrics; 1990 Aug; 21(3):119-23. PubMed ID: 2234315
[TBL] [Abstract][Full Text] [Related]
19. Photosensitized killing of cultured fibroblasts from patients with peroxisomal disorders due to pyrene fatty acid-mediated ultraviolet damage.
Hoefler G; Paschke E; Hoefler S; Moser AB; Moser HW
J Clin Invest; 1991 Dec; 88(6):1873-9. PubMed ID: 1752949
[TBL] [Abstract][Full Text] [Related]
20. Peroxisomal disorders. Neurodevelopmental and biochemical aspects.
Brown FR; Voigt R; Singh AK; Singh I
Am J Dis Child; 1993 Jun; 147(6):617-26. PubMed ID: 7685145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
